Laurentiu Vlad - 27 Jul 2022 Form 3 Insider Report for MAIA Biotechnology, Inc. (MAIA)

Role
Director
Signature
/s/ Laurentiu Vlad
Issuer symbol
MAIA
Transactions as of
27 Jul 2022
Net transactions value
$0
Form type
3
Filing time
27 Jul 2022, 18:24:27 UTC
Next filing
02 Aug 2022
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
holding MAIA Common Stock 371,933 27 Jul 2022 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
holding MAIA Stock Options 27 Jul 2022 Common Stock 15,000 $1.80 Direct F2
holding MAIA Stock Options 27 Jul 2022 Common Stock 18,000 $10.00 Direct F3
holding MAIA Warrants 27 Jul 2022 Common Stock 903 $6.00 Direct F4
holding MAIA Warrants 27 Jul 2022 Common Stock 8,562 $6.00 Direct F5
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Mr. Vlad beneficially owns 371,933 shares of common stock.
F2 Represents an option to purchase shares of Common Stock granted pursuant to the 2020 Equity Incentive Plan. These options vested in 12 equal monthly installments beginning on December 15, 2020.
F3 Represents an option to purchase shares of Common Stock granted pursuant to the 2020 Equity Incentive Plan. These options vest in 12 equal monthly installments beginning on November 15, 2021.
F4 Each Warrant became exercisable on the date of issuance of May 6, 2020, and expires on the earliest to occur of: (a) May 31 2027; or (b) immediately prior to the closing of any change of control of the issuer.
F5 Each Warrant became exercisable on the date of issuance of April 15, 2021, and expires on the earliest to occur of: (a) April 14, 2028; or (b) immediately prior to the closing of any change of control of the issuer.